Kinetics of high-dose intravenous morphine in cardiac surgery patients
- PMID: 1269215
- DOI: 10.1002/cpt1976196752
Kinetics of high-dose intravenous morphine in cardiac surgery patients
Abstract
Ten patients received 1.0 mg/kg of morphine sulfate by constant-rate intravenous infusion at 5 mg/min over 9 to 27 min. Multiple arterial blood samples were drawn during the first 30 to 151 min after termination of the infusion, prior to institution of cardiopulmonary bypass. Postinfusion plasma concentrations were fitted by computer to biexponential functions consistent with a 2-compartment open pharmacokinetic model. Mean (+/- SE) pharmacokinetic parameters were: volume of central compartment, 0.09 +/- 0.03 L/kg; total apparent volume of distribution, 1.02 +/- 0.09 L/kg; distribution T 1/2, 0.90 +/- 0.09 min; apparent elimination T 1/2, 137 +/- 14 min; total clearance, 378 +/- 63 ml/min. Thus distribution of morphine is very rapid, but the apparent volume of distribution is only slightly larger than body weight, suggesting limited tissue uptake. Since apparent elimination T 1/2s are similar to those reported after smaller doses, evidence of saturable or capacity-linked elimination is lacking. Total clearances, representing mainly hepatic clearance, averaged about 25% of hepatic blood flow, suggesting clinically important first-pass metabolism of oral morphine.
Similar articles
-
High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.Clin Pharmacokinet. 1986 Mar-Apr;11(2):87-106. doi: 10.2165/00003088-198611020-00001. Clin Pharmacokinet. 1986. PMID: 3514045 Review.
-
Kinetics of intravenous and intramuscular morphine.Clin Pharmacol Ther. 1978 Jul;24(1):52-9. doi: 10.1002/cpt197824152. Clin Pharmacol Ther. 1978. PMID: 657720
-
[Prolonged intravenous infusion of morphine. Pharmacokinetic study].Ann Fr Anesth Reanim. 1987;6(1):22-8. doi: 10.1016/s0750-7658(87)80005-9. Ann Fr Anesth Reanim. 1987. PMID: 3578942 French.
-
Pharmacokinetics and physiological effects of intravenous hydromorphone in conscious dogs.J Vet Pharmacol Ther. 2008 Aug;31(4):334-43. doi: 10.1111/j.1365-2885.2008.00966.x. J Vet Pharmacol Ther. 2008. PMID: 18638294
-
Clinical pharmacokinetics of the newer intravenous anaesthetic agents.Clin Pharmacokinet. 1986 Jan-Feb;11(1):18-35. doi: 10.2165/00003088-198611010-00002. Clin Pharmacokinet. 1986. PMID: 3512140 Review.
Cited by
-
Kinetic disposition of morphine in young males after intravenous loading and maintenance infusions.Can Anaesth Soc J. 1986 Mar;33(2):145-9. doi: 10.1007/BF03010823. Can Anaesth Soc J. 1986. PMID: 3697811
-
Pharmacokinetics of intramuscular nicomorphine and its metabolites in man.Eur J Clin Pharmacol. 1991;41(4):375-8. doi: 10.1007/BF00314971. Eur J Clin Pharmacol. 1991. PMID: 1804655
-
High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.Clin Pharmacokinet. 1986 Mar-Apr;11(2):87-106. doi: 10.2165/00003088-198611020-00001. Clin Pharmacokinet. 1986. PMID: 3514045 Review.
-
Drastic improvement in the rectal absorption profile of morphine in man.Eur J Clin Pharmacol. 1985;29(1):119-21. doi: 10.1007/BF00547380. Eur J Clin Pharmacol. 1985. PMID: 4054201
-
Pharmacokinetics of nicomorphine and its metabolites in man after epidural administration.Pharm Weekbl Sci. 1991 Jun 21;13(3):142-7. doi: 10.1007/BF01981532. Pharm Weekbl Sci. 1991. PMID: 1923705